- Home
- BIOA
BIOA
BioAge Labs Inc. Common Stock
as 11-14-2024 4:00pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $42.33 | AVG Volume (30 days): | 271.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -33.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.30 - $26.62 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BioAge Labs Inc. Common Stock News
BIOA Breaking Stock News: Dive into BIOA Ticker-Specific Updates for Smart Investing
TipRanks
2 days ago
BioAge Labs Reports Strong Q3 2024 Achievements
GlobeNewswire
7 days ago
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
11 days ago
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
GlobeNewswire
22 days ago
BioAge Labs to Present at Jefferies London Healthcare Conference
Investing.com
25 days ago
Wall Street analysts initiate coverage of BioAge Labs
Motley Fool
a month ago
Prediction: These 2 Stocks Could Soar in 2025
Motley Fool
a month ago
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
GuruFocus.com
a month ago
RA Capital Management, L.P. Acquires New Stake in Bioage Labs Inc
Compare BIOA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BIOA BioAge Labs Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.